Literature DB >> 15807845

CpG oligodeoxynucleotides promote the host protective response against infection with Cryptococcus neoformans through induction of interferon-gamma production by CD4+ T cells.

K Miyagi1, K Kawakami, Y Kinjo, K Uezu, T Kinjo, K Nakamura, A Saito.   

Abstract

In the present study, we elucidated the effect of synthetic CpG-containing oligodeoxynucleotides (ODN) on pulmonary and disseminated infection caused by Cryptococcus neoformans. CDF-1 mice were inoculated intratracheally with a highly virulent strain of this pathogen, which resulted in massive bacterial growth in the lung, dissemination to the brain and death. Administration of CpG-ODN promoted the clearance of C. neoformans in the lungs, decreased their dissemination to brain and prolonged the survival of infected mice. These effects correlated well with the enhanced production of interleukin (IL)-12 and interferon (IFN)-gamma and attenuated secretion of IL-4 in bronchoalveolar lavage fluids (BALF) and promoted development of Th1 cells, as indicated by the increased production of IFN-gamma by paratracheal lymph node cells upon restimulation with cryptococcal antigens. The IFN-gamma synthesis in BALF was inhibited by depletion of CD8(+) and CD4(+) T cells on days 7 and 14 after infection, respectively, but not by depletion of NK and gammadelta T cells. Consistent with these data, intracellular expression of IFN-gamma was detected predominantly in CD8(+) and CD4(+) T cells in the lung on days 7 and 14, respectively. The protective effect of CpG-ODN, as shown by the prolonged survival, was completely and partially inhibited by depletion of CD4(+) or CD8(+) T cells, respectively, but not by depletion of other cells. Finally, TNF-alpha was markedly induced by CpG-ODN, and the protective effect of this agent was strongly inhibited by neutralizing anti-TNF-alpha MoAb. Our results indicate that CpG-ODN alters the Th1-Th2 cytokine balance and promotes host resistance against infection with C. neoformans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15807845      PMCID: PMC1809361          DOI: 10.1111/j.1365-2249.2005.02772.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  51 in total

1.  Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells.

Authors:  T Sparwasser; E S Koch; R M Vabulas; K Heeg; G B Lipford; J W Ellwart; H Wagner
Journal:  Eur J Immunol       Date:  1998-06       Impact factor: 5.532

2.  Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.

Authors:  T Jakob; P S Walker; A M Krieg; M C Udey; J C Vogel
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

3.  CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.

Authors:  S Zimmermann; O Egeter; S Hausmann; G B Lipford; M Röcken; H Wagner; K Heeg
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

4.  CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants.

Authors:  G B Lipford; M Bauer; C Blank; R Reiter; H Wagner; K Heeg
Journal:  Eur J Immunol       Date:  1997-09       Impact factor: 5.532

5.  Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice.

Authors:  K Kawakami; Y Koguchi; M H Qureshi; Y Kinjo; S Yara; A Miyazato; M Kurimoto; K Takeda; S Akira; A Saito
Journal:  FEMS Microbiol Lett       Date:  2000-05-01       Impact factor: 2.742

6.  IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells.

Authors:  K Kawakami; Y Koguchi; M H Qureshi; A Miyazato; S Yara; Y Kinjo; Y Iwakura; K Takeda; S Akira; M Kurimoto; A Saito
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

7.  IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production.

Authors:  K Kawakami; M H Qureshi; T Zhang; H Okamura; M Kurimoto; A Saito
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

8.  T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice.

Authors:  R R Yuan; A Casadevall; J Oh; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

9.  Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12.

Authors:  K Kawakami; M Tohyama; X Qifeng; A Saito
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

10.  CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge.

Authors:  A M Krieg; L Love-Homan; A K Yi; J T Harty
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

View more
  12 in total

1.  Innate-immunity cytokines induced by very small size proteoliposomes, a Neisseria-derived immunological adjuvant.

Authors:  C Venier; M D Guthmann; L E Fernández; L Fainboim
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

2.  CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes.

Authors:  Tajie H Harris; John M Mansfield; Donna M Paulnock
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

3.  New insights on the pathogenesis of invasive Cryptococcus neoformans infection.

Authors:  Helene C Eisenman; Arturo Casadevall; Erin E McClelland
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

Review 4.  Vaccine adjuvants: current challenges and future approaches.

Authors:  Jennifer H Wilson-Welder; Maria P Torres; Matt J Kipper; Surya K Mallapragada; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

5.  Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosis.

Authors:  Qing Zhou; Ruth A Gault; Thomas R Kozel; William J Murphy
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 6.  Antiinfective applications of toll-like receptor 9 agonists.

Authors:  Arthur M Krieg
Journal:  Proc Am Thorac Soc       Date:  2007-07

Review 7.  Pathogen and host genetics underpinning cryptococcal disease.

Authors:  Carolina Coelho; Rhys A Farrer
Journal:  Adv Genet       Date:  2020-03-18       Impact factor: 3.880

8.  Intraperitoneal prophylaxis with CpG oligodeoxynucleotides protects neutropenic mice against intracerebral Escherichia coli K1 infection.

Authors:  Sandra Ribes; Tanja Meister; Martina Ott; Sandra Redlich; Hana Janova; Uwe-Karsten Hanisch; Stefan Nessler; Roland Nau
Journal:  J Neuroinflammation       Date:  2014-01-23       Impact factor: 8.322

9.  Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides.

Authors:  Jennifer M Dan; Jennifer P Wang; Chrono K Lee; Stuart M Levitz
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

10.  Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.

Authors:  Elizabeth B Norton; John D Clements; Thomas G Voss; Lucia Cárdenas-Freytag
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.